DOP2008000021A - Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidad - Google Patents
Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidadInfo
- Publication number
- DOP2008000021A DOP2008000021A DO2008000021A DO2008000021A DOP2008000021A DO P2008000021 A DOP2008000021 A DO P2008000021A DO 2008000021 A DO2008000021 A DO 2008000021A DO 2008000021 A DO2008000021 A DO 2008000021A DO P2008000021 A DOP2008000021 A DO P2008000021A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- agent
- orlistat
- pharmaceutical composition
- composition
- obesity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 3
- 229960001243 orlistat Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 239000006096 absorbing agent Substances 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 2
- 239000012895 dilution Substances 0.000 abstract 2
- 239000007884 disintegrant Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2007002287A CL53426B (enrdf_load_stackoverflow) | 2007-08-06 | 2007-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2008000021A true DOP2008000021A (es) | 2009-11-30 |
Family
ID=51359501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2008000021A DOP2008000021A (es) | 2007-08-06 | 2008-04-10 | Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidad |
Country Status (7)
| Country | Link |
|---|---|
| CL (1) | CL53426B (enrdf_load_stackoverflow) |
| CR (1) | CR10132A (enrdf_load_stackoverflow) |
| DO (1) | DOP2008000021A (enrdf_load_stackoverflow) |
| MX (1) | MX2008010082A (enrdf_load_stackoverflow) |
| PA (1) | PA8786701A1 (enrdf_load_stackoverflow) |
| PE (1) | PE20091224A1 (enrdf_load_stackoverflow) |
| SV (1) | SV2009002991A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216542B1 (pl) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
-
2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/es active IP Right Grant
-
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/es unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/es unknown
- 2008-07-07 CR CR10132A patent/CR10132A/es not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/es unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CR10132A (es) | 2008-10-28 |
| PA8786701A1 (es) | 2009-04-23 |
| CL53426B (enrdf_load_stackoverflow) | 2016-11-28 |
| SV2009002991A (es) | 2009-04-16 |
| CL2007002287A1 (enrdf_load_stackoverflow) | 2007-12-14 |
| PE20091224A1 (es) | 2009-08-26 |
| MX2008010082A (es) | 2009-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0713777B8 (pt) | processo para preparação de formulações de pó seco de um sal de glicopirrônio para inalação | |
| MX365568B (es) | Granulos de dispersion rapida, comprimidos de disolucion oral y metodos. | |
| SI2198007T1 (en) | Pharmaceutical compositions containing Clostridium difficile A and B toxoids | |
| BRPI0606332A2 (pt) | composição farmacêutica de bendamustina, preparação liofilizada, forma de dosagem farmacêutica, método para obter aprovação oficial para um produto de bendamustina, processo para fabricar uma preparação liofilizada de bendamustina, solução ou dispersão de pré-liofilização de bendamustina, pó liofilizado, método para preparar uma preparação liofilizada de bendamustina, formulação para liofilização, e, uso de uma solução farmaceuticamente aceitável | |
| CO6720961A2 (es) | Imidazopiridazinas sustituidas | |
| BR112013015786A2 (pt) | composição de agente de formação de imagem, método de formação de imagem de pelo menos uma parte de um indivíduo, e, método para preparar uma composição de polipeptídeo conjugado com quelante | |
| AR077190A1 (es) | Composiciones y metodos para preparar composiciones inmunogenicas conjugadas de polisacaridos capsulares de staphylococcus aureus de los serotipos 5 y 8 | |
| UY37952A (es) | Formulaciones de un inhibidor de la quinasa trk macrocíclica | |
| HRP20200055T1 (hr) | Eutektičke formulacije ciklobenzaprin-klorovodika i manitola | |
| ES2923214T3 (es) | Composición farmacéutica que comprende mesilato de lenvatinib | |
| CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
| CL2015001975A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
| WO2008127358A3 (en) | Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof | |
| HRP20140876T1 (hr) | Rifaksimin u prahu, postupak za dobivanje istog i pripravci sa kontroliranim oslobađanjem koji sadrže navedeni rifaksimin te koji su korisni za dobivanje dugotrajnog djelovanja | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| BR112015029773A2 (pt) | pós revestidos com aroma | |
| WO2016184577A3 (en) | Dry powder composition comprising long-chain rna | |
| BR112021019104A2 (pt) | Micropartículas secas | |
| BR112018074381A2 (pt) | [8-(fenil sulfonil)-3,8-diazabiciclo[3.2.1]oct-3-il] (1h-1,2,3-triazol-4-il)metanonas | |
| PH12020551412A1 (en) | Pharmaceutical composition including sodium alkyl sulfate | |
| MY209656A (en) | Compositions and methods of enhancing 5-hydroxytryptophan bioavailability | |
| TW201707702A (zh) | 一種含有喹啉衍生物或其鹽的醫藥組成物 | |
| DOP2008000021A (es) | Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat, procedimiento de preparacion de la composicion y su uso para el tratamiento de la obesidad | |
| WO2006130703A3 (en) | Modified release formulations of anti-irritability drugs | |
| WO2011056785A3 (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |